In Vitro methods for the study of mechanisms of developmental toxicology

Developmental and Reproductive Toxicology: A Practical Approach

Volumn , Issue , 2005, Pages 647-695

  Harris, Craig ^a   Hansen, Jason H ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123816132     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (266)

1. Schwetz, B.A., Morrissey, R.E., Welsch, F., and Kavlock, R.A., In vitro teratology, Environ. Health Perspect., 94, 265, 1991.
2. Welsch, F., In vitro approaches to the elucidation of mechanisms of chemical teratogenesis, Teratology, 46, 3, 1992.
3. Flynn, T.J., Teratological research using in vitro systems. I. Mammalian whole embryo culture. Environ. Health Perspect, 72, 203, 1987.
4. Kimmel, G.L. and Kochhar, D.M., In Vitro Methods in Developmental Toxicology, CRC Press, Boca Raton, 1990.
5. Sadler, T.W., Horton, W.E., Jr., and Hunter, E.S., Mammalian embryos in culture: a new approach to investigating normal and abnormal developmental mechanisms, Prog. Clin. Biol. Res., 171, 227, 1985.
6. Sadler, T.W., and Warner, C.W., Use of whole embryo culture for evaluating toxicity and teratogenicity, Pharmacol. Rev, 36, 145S, 1984.
7. Steele, C.E., Whole embryo culture and teratogenesis, Human Reprod., 6, 144, 1991.
8. New, D.A.T., Whole embryo culture, teratogenesis, and the estimation of teratologic risk, Teratology, 42, 635, 1990.
9. Wilson, J.G., Survey of in vitro systems: their potential use in teratogenicity screening, in Handbook of Teratology, Wilson, J.G. and Fraser, F.C., Eds., Plenum Press, New York, 1978, p. 135.
10. New, D.A.T., Introduction, in Postimplantation Mammalian Embryos: A Practical Approach, Copp, A.J. and Cockroft, D.L., Eds., IRL Press, Oxford, 1990, p. 1.
11. Austin, C.R., Embryo transfer and sensitivity to teratogenesis, Nature, 244, 333, 1973.
12. Brachet, A., Dévelopment in vitro de blastomères et jeunes embryon de mammifères, C.R. Acad. Sci. Paris, 155, 1191, 1912.
13. Spielmann, H. and Vogel, R., Unique role of studies on preimplantation embryos to understand mechanisms of embryotoxicity in early pregnancy, Crit. Rev. Toxicol, 20, 51, 1989
14. Lawitts, J.A. and Biggers, J.D., Culture of preimplantation embryos, Methods Enzymol, 225, 153, 1993.
15. Pratt, H.P.M., Isolation, culture and manipulation of pre-implantation mouse embryos, in Mammalian Development: A Practical Approach, Monk, M., Ed., IRL Press, Washington, D.C., 1987, p. 13.
16. Blakenship, A.L., Suffia, M.C., Matsumura, F., Walsh, K.J., and Wiley, L.M., 2,3,7,8-tetrachlorod-ibenzo-p-dioxin (TCDD) accelerates differentiation of murine preimplantation embryos in vitro, Reprod. Toxicol., 7, 255, 1993.
17. Oudiz, D.J., Walsh, K., and Wiley, L.M., Ethylene glycol monomethyl ether (EGME) exposure of male mice produces a decrease in cell proliferation of preimplantation embryos, Reprod. Toxicol., 7, 101, 1993.
18. Kholkute, S.D., Rodriguez, J., Dukelow, W.R., Effects of polychlorinated biphenyls (PCBs) on in vitro fertilization in the mouse, Reprod. Toxicol, 8, 69, 1994.
19. McNutt, T.L. and Harris, C., Glutathione and cysteine modulation in bovine oviduct epithelium cells cultured in vitro, Teratology, 49, 413, 1994.
20. McNutt, T.L. and Harris, C., Influence of lindane on cysteine (CYS) and glutathione (GSH) levels in bovine oviduct epithelium cells cultured in vitro, The Toxicologist, 15, 251, 1995.
21. Goto, Y., Noda, Y., Mori, T., and Nakano, M., Increased generation of reactive oxygen species in embryos cultured in vitro, Free Rad. Biol. Med, 15, 69, 1993.
22. Goto, Y., Noda, Y., Narimoto, K., Umaoka, Y., and Mori, T., Oxidative stress on mouse embryo development in vitro, Free Rad. Biol. Med., 13, 47, 1992.
23. Gardiner, C.S. and Reed D.J., Status of glutathione during oxidant-induced oxidative stress in the preimplantation mouse embryo. Biol. Reprod., 51, 1307, 1994.
24. Borland, R.M. and Tasca, R.J., Inhibition of L-methionine uptake and incorporation by chlorpromazine in preimplantation mouse embryos, J. Reprod. Fert., 42, 473, 1975.
25. Heyner, S., Rao, L.V., Jarett, L., and Smith, R.M., Preimplantation mouse embryos internalize maternal insulin via receptor-mediated endocytosis: pattern of uptake and functional correlations, Dev. Biol., 134, 48, 1989.
26. Sellens, M.H., Stein, S., and Sherman, M.I., Protein and free amino acid content in preimplantation mouse embryos and in blastocysts under various culture conditions, J. Reprod. Fert., 61, 307, 1981.
27. Poueymirou, W.T. and Schultz, R.M., Regulation of mouse preimplantation development: inhibition of synthesis of proteins in the two-cell embryo that require transcription by inhibitors of cAMP-dependent protein kinase, Dev. Biol, 133, 588, 1989.
28. Murach, K., Frei, M., Gerhauser, D., and Illmensee, K., Protein synthesis in embryonic tissues during mouse postimplantation development, J. Cell. Biol., 44, 19, 1990.
29. Spielman, H. and Eibs, H.-G., Recent progress in teratology: a survey of methods for the study of drug actions during the preimplantation period, Arzneim.-Forsch, 28, 1733, 1978.
30. Dumoulin, J.C.M., Evers, J.L.H., Bakker, J.A., Bras, M., Pieters, M.H.E.C., and Geraedts, J.P.M., Temporal effects of taurine on mouse preimplantation development in vitro, Human Reprod, 7, 403, 1992.
31. Iyer, P., Martin, J.E., and Irvin, R.T., Role of biotransformation in the in vitro preimplantation embryotoxicity of naphthalene, Toxicology, 66, 257, 1991.
32. Winkle, L.J.V., Amino acid transport in developing animal oocytes and early conceptuses, Biochim. Biophys. Acta, 947, 173, 1988.
33. Mattson, B.A., Rosenblum, I.Y., Smith, R.M. and Heyner, S. Autoradiographic evidence for insulin and insulin-like growth factor binding to early mouse embryos, Diabetes, 37, 585, 1988.
34. Rao, L.V., Wikarczuk, M.L., and Heyner, S., Functional roles of insulin and insulinlike growth factors in preimplantation mouse embryo development, In Vitro Cell. Dev. Biol., 26, 1043, 1990.
35. Niimura, S. and Ishida, K., Immunohistochemical demonstration of prostaglandin E-2 in preimplantation mouse embryos, J. Reprod. Fert., 80, 505, 1987.
36. Biggers, J.D. and Borland, R.M. Physiological aspects of growth and development in the preimplantation mammalian embryo. Ann. Rev. Physiol. 38, 95, 1976.
37. Kane, M.T. and Bavister, B.D., Vitamin requirements for development of eight-cell hamster embryos to hatching blastocysts in vitro, Biol. Reprod., 39, 1137, 1988.
38. Butler, J.E., Lechene, C., and Biggers, J.D., Noninvasive measurement of glucose uptake by two populations of murine embryos, Biol. Reprod., 39, 779,1988.
39. Seshagiri, P.B. and Bavister, B.D., Glucose inhibits development of hamster 8-cell embryos in vitro, Biol. Reprod., 40, 599, 1989
40. McKiernan, S.H., Bavister, B.D., and Tasca, R.J., Energy substrate requirements for in vitro development of hamster 1- and 2-cell embryos to the blastocyst stage, Human Reprod., 6, 64, 1991.
41. Brinster, R.L., Studies on the development of mouse embryos in vitro. II. The effect of energy source. J. Exp. Zool., 158, 59, 1965.
42. Barbehenn, E.K., Wales, R.G., and Lowry, O.H., Measure of metabolites in single preimplantation embryos; a new means to study metabolic control in early embryos, J. Embryol. Exp. Morph., 43, 29, 1978.
43. Gupta, J., Dey, S.K., and Dickman, Z., Evidence that "embryonic estrogen" is a factor which controls the development of the mouse preimplantation embryo, Steroids, 29, 363, 1977.
44. Wu, J.T., Metabolism of progesterone by preimplantation mouse blastocysts in culture, Biol. Reprod., 36, 549, 1987.
45. Garris, D.R., Role of the preimplantation embryo in the timing of LH-dependent progesterone secretion from the rat corpus luteum, Proc. Soc. Exp. Biol. Med, 170, 443, 1982.
46. Lamb, V.K. and Leese, H.J., Uptake of a mixture of amino acids by mouse blastocysts. J. Reprod. Fert., 102, 169, 1994.
47. Epstein, C.J. and Smith, S.A., Amino acid uptake and protein synthesis in preimplantation embryonic development, Biol. Reprod, 12, 82, 1973.
48. Bavister, B.D. and McKiernan, S.H., Regulation of hamster embryo development in vitro by amino acids, in Preimplantation Embryo Development, Bavister, B.D., Ed., Springer-Verlag, New York, 1993, p. 57.
49. Hsu, Y., Baskar, J., Stevens, L. and Rash, J., Development in vitro of mouse embryos from the two-cell egg stage to the early somite stage, J. Embryol. Exp. Morphol, 31, 235, 1974.
50. Hsu, Y.-C. In vitro development of individually cultured whole mouse embryos from blastocyst to early somite stage, Dev. Biol. 68, 453, 1979.
51. Kaufman, R.A., and Armant, D.R., In vitro exposure of preimplantation mouse embryos to cocaine and benzoylecgonine inhibits subsequent development, Teratology, 46, 85, 1992
52. Pollard, D.R., Baran, M.M. and Bachvarova, R., The effect of 5-bromodeoxyuridine on cell division and differentiation of preimplantation mouse embryos, J. Embryol. Exp. Morph., 35, 169, 1976.
53. Rothstein, J.L., Johnson, D., DeLoia, J.A., Skowronski, J., Solter, D., and Knowles, B., Gene expression during preimplantation mouse development, Genes Dev., 6, 1190, 1992.
54. Bolton, V.N., Oades, P.J. and Johnson, M.H. The relationship between cleavage, DNA replication and gene expression in the mouse 2-cell embryo, J. Embryol. Exp. Morphol, 79, 139, 1984.
55. Conover, J.C., Temeles, G.L., Zimmerman, J.W., Burke, B., and Schultz, R.M., Stage-specific expression of a family of proteins that are major products of zygotic gene activation in the mouse embryo, Dev. Biol., 144, 392, 1991
56. Christians, E., Campion, E., Thompson, E.M., and Renard, J.-P., Expression of the HSP 70.1 gene, a landmark of early zygotic activity in the mouse embryo, is restricted to the first burst of transcription, Development, 121, 113, 1995.
57. Kimber, S.J., Waterhouse, R., and Lindenberg, S., In vitro models for implantation of the mammalian embryo, in Preimplantation Embryo Development, Bavister, B.A., Ed., Springer-Verlag, New York, 1993, 244-263.
58. Lindenberg, S., Hyttel, P., Sjgren, A., and Greve, T., A comparative study of attachment of human, bovine and mouse blastocysts to uterine epithelial monolayer, Human Reprod, 4, 446, 1989.
59. New, D.A.T., Methods for the culture of postimplantation embryos of rodents, in Methods in Mammalian Embryology, Daniel, J.C., Jr., Ed., W.H. Freeman & Co., San Francisco, 1971, p. 305.
60. Cockroft, D.L., Dissection and culture of postimplantation embryos, in Postimplantation Mammalian Embryos: A Practical Approach, Copp, A.J. and Cockroft, D.L., Eds., IRL Press, Oxford, 1990, p. 15.
61. Sturm, K. and Tam, P.P.L., Isolation and culture of whole postimplantation embryos and germ layer derivatives, Methods Enzymol., 225, 164, 1993.
62. Freeman, S.J., Coakley, M.E., and Brown, N.A., Post-implantation embryo culture for studies of teratogenesis, in Biochemical Toxicology: A Practical Approach, Snell, K. and Mullock, B., Eds., IRL Press, Oxford, 1987, p. 4.
63. Tarlatzis, B.C., Sanyal, M.K., Biggers, W.J. and Naftolin, F., Continuous culture of the postimplantation rat conceptus, Biol. Reprod., 31, 415, 1984.
64. Kaufmann, M.H., Morphological stages of postimplantation embryonic development, in Postimplantation Mammalian Embryos: A Practical Approach, Copp, A.J. and Cockroft, D.L., Eds., IRL Press, Oxford, 1990, p. 81.
65. Naya M., Kito Y., Eto K., and Deguchi T., Development of rabbit whole embryo culture during organogenesis, Cong. Anom., 31, 153, 1991.
66. Ninomiya H., Kishida K., Ohno Y., Tsurumi K., and Eto K., Effects of trypan blue on rat and rabbit embryos cultured in vitro, Toxicol. In Vitro, 7, 707, 1993.
67. Pitt J. and Carney, E.W., Development of a morphologically-based scoring system for postimplantation New Zealand White rabbit embryos, Teratology, 59, 88, 1999.
68. Pitt J. and Carney, E.W. Evaluation of various toxicants in rabbit whole-embryo culture using a new morphologically-based evaluation system, Teratology, 59, 102, 1999.
69. Harris, C., Glutathione biosynthesis in the postimplantation rat conceptus in vitro, Toxicol. Appl. Pharmacol., 120, 247, 1993.
70. Hansen, J., Choe, Y., Carney, E.W., and Harris, C., Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses, Free Rad. Biol. Med., 30, 1078, 2001.
71. Hansen, J., Carney, E.W., and Harris, C., Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro, Reprod. Toxicol. 13, 547, 1999.
72. Fantel, A.G., Greenaway, J.C., Juchau, M.R., and Shepard, T.H., Teratogenic bioactivation of cyclophosphamide in vitro, Life Sci., 25, 67, 1979.
73. Faustman-Watts, E.M., Greenaway, J.C., Namkung, M.J., Fantel, A.G., and Juchau, M.R., Teratogenicity in vitro of 2-acetylaminofluorene: role of biotransformation in the rat, Teratology, 27, 19, 1983.
74. Greenaway, J.C., Bark, D.H., and Juchau, M.R., Embryotoxic effects of salicylates: role of biotransformation, Toxicol. Appl. Pharmacol, 74, 141, 1984.
75. Fantel, A.G., Greenaway, J.C. and Juchau, M.R., The embryotoxicity of adriamycin in rat embryos in vitro, Toxicol. Appl. Pharmacol, 80, 155, 1985.
76. Harris, C., Stark, K.L., Luchtel, D.L. and Juchau, M.R., Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens, Toxicol. Appl. Pharmacol., 101, 432, 1989.
77. Steele, C.E., Marlow, R., Turton, J., and Hicks, R.M., In vitro teratogenicity of retinoids, Br. J. Exp. Path., 68, 215, 1987.
78. Creech Kraft, J. and Juchau, M.R., Conceptal biotransformation of 4-oxo-all-trans-retinoic acid, 4-oxo-13-cis-retinoic acid and all-trans-retinoyl-beta-glucuronide in rat whole embryo culture, Biochem. Pharmacol., 43, 2289, 1992.
79. Klug, S., Lewandowski, C., Zappel, F., merker, H.-J., Nau, H. and Neubert, D., Effects of valproic acid, some of its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo, Arch. Toxicol. 64, 545, 1990.
80. Bruckner, A., Lee, Y.J., O'Shea, K.S., and Henneberry, R.C., Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture, Teratology, 27, 29, 1983.
81. Fantel, A.G., Greenaway, J.C., Walker, E., and Juchau, M.R., The toxicity of niridazole in rat embryos in vitro, Teratology, 33, 105, 1986.
82. Fantel, A.G., Greenaway, J.C. Shepard, T.H., Juchau, M.R., and Selleck, S.B., The teratogenicity of cytochalasin D and its inhibition by drug metabolism, Teratology, 23, 223, 1981.
83. Greenaway, J.C. and Fantel, A.G., Enhancement of rifampin teratogenicity in cultured rat embryos. Toxicol. Appl. Pharmacol, 69, 81, 1983.
84. Faustman-Watts, E.M., Namkung, M.J., Greenaway, J.C. and Juchau, M.R., Analyses of metabolites of 2-acetylaminofluorene generated in an embryo culture system: relationship of biotransformation to teratogenicity in vitro, Biochem. Pharmacol., 34, 2853, 1985.
85. Yang, H.-Y.L., Namkung, M.J., and Juchau, M.R. Cytochrome P-450-dependent biotransformation of a series of phenoxazone ethers in the rat conceptus during early organogenesis: evidence for multiple P-450 isozymes. Mol. Pharmacol., 34, 67, 1988.
86. Yang, H.-Y.L., Zelus, B.D. and Juchau, M.R., Organogenesis-stage cytochrome P450 isoforms: utilization of PCR for detection of CYP1A1 mRNA in rat conceptal tissues, Biochem. Biophys. Res. Commun., 178, 236, 1991.
87. Chapman, D.E., Yang, H.Y., Watters, J.J., and Juchau, M.R., Induction in vitro and complete coding region sequence of cytochrome P4501A1 cDNA from cultured whole rat conceptuses during early organogenesis, Biochem. Pharmacol., 48, 1807, 1994.
88. Martz, F., Failinger, C., III, and Blake, D.A., Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding on putative arene oxide metabolite in gestational tissue, J. Pharmacol. Exp. Ther., 203, 231, 1986.
89. Wells, P.G., Zubovits, J.T., Wong, S.T., Molinari, L.M., and Ali, S., Modulation of phenytoin teratogenicity and embryonic covalent binding by the cyclooxygenase inhibitor acetylsalicylic acid, caffeic acid, and a-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin H synthease, Toxicol. Appl. Pharmacol., 97, 192, 1989.
90. Kubow, S. and Wells, P.G., In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin H synthase, horseradish peroxidase, and thyroid peroxidase, Mol. Pharmacol., 35, 504, 1989.
91. Yu, W.K. and Wells, P.G., Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice, Toxicol. Appl. Pharmacol, 131, 1, 1995.
92. Roy, S.K., Mitra, A.K., Hilbelink, D.R., Dwornik, J.J., and Kulkarni, A.P., Lipoxygenase activity in rat embryos and its potential for xenobiotic oxidation, Biol. Neonate, 63, 297, 1993.
93. Liu, L. and Wells, P.G., DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: Phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2¢-deoxyguanosine in vitro and in vivo murine maternal hepatic and embryonic tissues, Free Rad. Biol. Med., 19, 639, 1995.
94. Nau, H., Pharmacokinetic aspects of in vitro teratogenicity studies: comparison to in vivo, in In Vitro Methods in Developmental Toxicology: Use in Defining Mechanisms and Risk Parameters, Kimmel, G.L. and Kochhar, D.M., Eds., CRC Press, Boca Raton, 1990, p. 29.
95. Mebus, C.A., Clarke, D.O., Stedman, D.B. and Welsch, F., 2-Methoxyethanol metabolism in pregnant CD-1 mice and embryos, Toxicol. Appl. Pharmacol, 112, 87, 1992.
96. Stedman D.B. and Welsch, F., Inhibition of DNA synthesis in mouse whole embryo culture by 2-methoxyacetic acid and attenuation of the effects by simple physiological compounds, Toxicol. Lett. 45, 111, 1989.
97. Scott, W.J., Duggan, C.A., Schreiner, C.M., Collins, M.D., and Nau, H., Intracellular pH of rodent embryos and its association with teratogenic response, in Approaches to Elucidate Mechanisms in Teratogenesis, Welsch, F., Ed., Hemisphere, New York, 1987, p. 99.
98. Nau, H. and Scott, W.J., Jr., Teratogenicity of valproic acid and related substances in the mouse: drug accumulation and pHi in the embryo during organogenesis and structure-activity considerations, Arch. Toxicol. Suppl., 11, 128, 1987.
99. Harris, C., Tan, W., Thorsrud, B.A., and Kopelman, R., Ultramicrofiberoptic pH sensors for measurement of real time responses to chemical insult in intact, organogenesis stage rat conceptuses in vitro, Teratology, 49, 413, 1994.
100. Terlouw, G.D.C. and Bechter, R., Comparison of the metabolic activity of yolk sac tissue in the whole embryo and isolated yolk sac culture, Reprod. Toxicol., 6, 85, 1992.
101. Lucier, G.W., Lui, E.M.K., and Lemartiniere, C.A., Metabolic activation/deactivation reactions during perinatal development, Environ. Health Perspect, 29, 7, 1979.
102. Harris, C., Fantel, A.G., and Juchau, M.R. Differential glutathione depletion in rat embryo vs. visceral yolk sac in vivo and in vitro by L-buthionine-S,R-sulfoximine, Biochem. Pharmacol, 35, 4437, 1986.
103. Harris, C., Stark, K.L., and Juchau, M.R. Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro, Teratology, 37, 577, 1988.
104. Harris, C., Namkung, M.J., and Juchau, M.R., Regulation of intracellular glutathione in rat embryos and visceral yolk sacs and its effects on 2-nitrosofluorene-induced malformations in the whole embryo culture system, Toxicol. Appl. Pharmacol, 88, 141, 1987.
105. Harris, C., Juchau, M.R., and Mirkes, P.E. The role of glutathione and Hsp70 in the acquisition of thermotolerance in postimplantation rat embryos, Teratology, 43, 229, 1991.
106. Slott, V.L. and Hales, B.F., Enhancement of the embryotoxicity of acrolein, but not phosporamide mustard, by glutathione depletion in rat embryos in vitro, Biochem. Pharmacol, 36, 2091, 1987.
107. Wong, M., Helston, L.M.J., and Wells, P.G., Enhancement of murine phenytoin teratogenicity by the g-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate, Teratology, 40, 127, 1089.
108. Naya, M., Mataki, Y., Takanira, H. Deguchi, T., and Yasuda, M., Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice, Teratology, 41, 275, 1990.
109. Griffith, O.W. and Meister, A., Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butylhomocysteine sulfoximine), J. Biol. Chem, 254, 7558, 1979.
110. Lee, E. and Harris, C., Differential chemical modulation of glutathione and cysteine status in rat embryo and visceral yolk sac in vitro: microinjection and addition to the culture medium, In Vitro Toxicol. (in press), 1995.
111. Stark, K.L., Harris, C., and Juchau, M.R., Embryotoxicity elicited by inhibition of gamma-glutamyl transferase by acivicin and transferase antibodies in cultured rat embryos, Toxicol. Appl. Pharmacol., 89, 88, 1987.
112. Stark, K.L., Lee, Q.P., Namkung, M.J., Harris, C., and Juchau, M.R., Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro, J. Pharmacol. Exp. Ther., 255, 74, 1990.
113. Rowe, P.B. and Kalaizis, A., Serine metabolism in rat embryos undergoing organogenesis, J. Embryo. Exp. Morphol., 87, 137, 1985.
114. Beckman, D.A., Pugarelli, J.E., Jensen, M., Koszalka, T.R., Brent, R.L., and Lloyd, J.B., Sources of amino acid for protein synthesis during early organogenesis in the rat. I. Relative contributions of free amino acids and of proteins, Placenta, 11, 109, 1990.
115. Beckman, D.A., Pugarelli, J.E., Jensen, M., Koszalka, T.R., Brent, R.L., and Lloyd, J.B., Sources of amino acid for protein synthesis during early organogenesis in the rat. II. Exchange with amino acid and protein pools in embryo and yolk sac, Placenta, 12, 37, 1991.
116. Jenkinson, P.C., Anderson, D., and Gangolli, S.D., Malformations induced in cultured rat embryos by enzymatically generated active oxygen species, Teratogen. Carcinogen. Mutagen., 6, 547, 1986.
117. Eriksson, U.J. and Borg, L.A.H., Protection by free radical scavenging enzymes against glucose induced embryonic malformations in vitro, Diabetologia, 34, 325, 1991.
118. Tabacova, S. and Hunter, E.S., Modulation of arsenic teratogenicity by free radical scavengers, Teratology, 47, 390, 1993.
119. Wells, P.G., Leeder, J.S., and Winn, L.M., Phenytoin-initiated protein oxidation in murine embryo culture: a potential molecular mechanism mediating phenytoin teratogenicity, The Toxicologist, 15, 276, 1995.
120. Hockenberry, D.M., Oltvai, Z.N., Yin, X.M., Millman, C.L., and Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell, 75, 241,1993.
121. Smedley, M.J. and Stanisstreet, M., Calcium and neurulation in mammalian embryos, J. Embryol. Exp. Morph., 89, 1, 1985.
122. Smedley, M.J. and Stanisstreet, M., Calcium and neurulation in mammalian embryos. II. Effects of cytoskeletal inhibitors and calcium antagonists on the neural folds of rat embryos, J. Embryol. Exp. Morph., 93, 167, 1986.
123. Stein, G., Srivastava, M.K., Merker, H.-J., and Neubert, D., Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture, Arch. Toxicol., 64, 623, 1990.
124. Lee, H. and Nagele, R.G., Toxic and teratologic effects of verapamil on early chick embryos: evidence for the involvement of calcium in neural tube closure, Teratology, 33, 203, 1986.
125. Beaudoin, A.R., NAD precursors as antiteratogens against aminothiadiazole, Teratology, 13, 95, 1976.
126. Thorsrud, B.A. and Harris, C., Real time, micro-fiberoptic monitoring of endogenous fluorescence in the rat conceptus during hypoxia, Teratology, 48, 343, 1993.
127. Krowke, R. and Neubert, D., Embryonic intermediary metabolism under normal and pathological conditions, in Handbook of Teratology, Wilson, J.G. and Fraser, F.C., Eds., Plenum Press, New York, 1978, p. 117.
128. Kitchin, K.T., Sanyal, M.K., and Schmid, B.P., A coupled microsomal-activating/embryo culture system: toxicity of reduced b-nicotinamide adenine dinucleotide phosphate(NADPH), Biochem. Pharmac., 30, 985, 1981.
129. Thorsrud, B.A. and Harris, C., Real time microfiberoptic redox fluorometry: modulation of the pyridine nucleotide status of the organogenesis-stage rat visceral yolk sac with cyanide and alloxan, Toxicol. Appl. Pharmacol., 135, 237, 1995.
130. Freeman, S.J. and Lloyd, J.B., Evidence that suramin and sodium aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutrition, Chem. Biol. Interact., 58, 149, 1986.
131. Freeman, S.J. and Lloyd, J.B., Inhibition of proteolysis in rat yolk sac as a cause of teratogenesis. Effects of leupeptin in vitro and in vivo, J. Embryol. Exp. Morphol, 78, 183, 1983.
132. Ambroso, J.L. and Harris, C., Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro, Teratology, 48, 213, 1993.
133. Ambroso, J.A. and Harris, C., In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl-phenylalanine-alanine-diazomethane (Z-Phe-Ala-CHN2) and benzyloxycarbonyl-phenyla-lanine-phenylalanine-diazomethane (Z-Phe-Phe-CHN2), Teratology, 50, 214, 1994.
134. Ambroso, J.L. and Harris, C., Chloroquine accumulation and alterations of proteolysis and pinocytosis in the rat conceptus in vitro, Biochem. Pharmacol., 47, 679, 1994.
135. Hunter, E.S., III, Phillips, L.S., Goldstein, S., and Sadler, T.W., Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor, Teratology, 43, 331, 1991.
136. Lerman, S., Koszalka, T.R., Jensen, M., Andrew, C. L., Beckman, D.A. and Brent, R.L., In vitro studies on the effect of yolk sac antisera on functions of the viscera yolk sac. I. Pinocytosis and transport of small molecules, Teratology, 34, 335, 1986.
137. Marlow, R. and Freeman, S.J., Differential effect of zinc on teratogen-induced inhibition of pinocytosis by cultured rat yolk sac, Life Sci., 40, 1717, 1987.
138. Pinter, E., Reece, E.A., Leranth, C.Z., Sanyal, M.K., Hobbins, J.C., Mahoney, M.J., and Naftolin, F., Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions, Teratology, 33, 73, 1986.
139. Dunton, A., Al-Alousi, L.A., Pratten, M.K., and Beck, F., The giant yolk sac: a model for studying early placental transport, J. Anat., 145, 189, 1986.
140. Freinkel, N., Lewis, N.J., Akawawa, S., Roth, S.I., and Gorman, L., The honeybee syndrome - implications of the teratogenicity of mannose in rat-embryo culture, N. Engl. J. Med., 310, 223, 1984.
141. Tanimura, T. and Shepard, T.H., Glucose metabolism by rat embryos in vitro, Proc. Soc. Exp. Biol. Med., 135, 51, 1970.
142. Ellington, S.K.L., In vitro analysis of glucose metabolism and embryonic growth in postimplantation rat embryos, Development, 100, 431, 1987.
143. Clough, J.R. and Whittingham, D.G., Metabolism of [14C]glucose by postimplantation mouse embryos in vitro, J. Embryol. Exp. Morph., 74, 133, 1983.
144. Moore, D.C.P., Stanistreet, M., Beck, F., and Clarke, C.A., The effects of mannose on rat embryos grown in vitro, Life Sci., 41, 1885, 1987.
145. Hiranruengchok, R. and Harris, C., Formation of protein-glutathione mixed disulfides in the developing rat conceptus following diamide treatment in vitro, Teratology, 52, 196, 1995.
146. Hiranruengchok, R. and Harris, C., Glutathione oxidation and embryotoxicity elicited by diamide in the developing rat conceptus in vitro, Toxicol. Appl. Pharmacol, 120, 62, 1993.
147. Hiranruengchok, R. and Harris, C., Diamide-induced alterations of intracellular thiol status and the regulation of glucose metabolism in the developing rat conceptus in vitro, Teratology, 52, 205, 1995.
148. Horton, W.E., Jr. and Sadler, T.W., Effects on maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, b-hydroxybutyrate, Diabetes, 32, 610, 1983.
149. Sadler, T.W., Hunter, E.S., III, Balkan, W., and Horton, W.E., Jr., Effects of maternal diabetes on embryogenesis, Am. J. Perinatol, 5, 319, 1988.
150. Sadler, T.W., Denno, K.M. and Hunter, E.S., III, Effects of altered glucose metabolism during gastrulation and neurulation stages of embryogenesis, Ann. New York Acad. Sci., 678, 48, 1993.
151. Eriksson, U.J. and Borg, L.A.H., Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos, Diabetes, 42, 411, 1993.
152. Denno, K.M. and Sadler T.W., Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture, Teratology, 42, 565, 1990.
153. Sulik, K.K. and Sadler, T.W., Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies, Ann. New York Acad. Sci., 678, 8, 1993.
154. Bolon, B., Welsch, F., and Morgan, K.T., Methanol-induced neural tube defects in mice: pathogenesis during neurulation, Teratology, 49, 497, 1994.
155. Cuthbertson, R.A. and Beck, F., Postimplantation whole embryo culture: a new method for studying ocular development, Invest. Ophthalmol. Vis. Sci., 31, 1653, 1990.
156. Seegmiller, R.E., Harris C., Luchtel, D.L., and Juchau, M.R., Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro, Teratology, 43, 133, 1991.
157. Alles, A.J. and Sulik, K.K., Retinoic-acid-induced limb-reduction defects: perturbation of zones of programmed cell death as a pathogenic mechanism, Teratology, 40, 163, 1989.
158. Eto, K. and Takakubo, F., The role of the yolk sac in craniofacial development of cultured rat embryos, J. Craniofac. Genet. Dev. Biol, 5, 357, 1985.
159. Baltz, J.M., Biggers, J.D., and Lechene, C., Intracellular pH regulation by the preimplantation embryo, in Preimplantation Embryo Development, Bavister, B.A., Ed., Springer-Verlag, New York, 1993, p. 97.
160. Gressens, P., Hill, J.M., Gozes, I., Fridkin, M., and Brenneman, D.E., Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos, Nature, 362, 155, 1993.
161. Yasuda, Y., Nishi, N., Takahashi, J.A., Konishi, H., Ohara, I., Fujita, H., Ohta, M., Itoh, N., Hatanaka, M., and Tanimura, T., Induction of avascular yolk sac due to reduction of basic fibroblast growth factor by retinoic acid in mice, Dev. Biol, 150, 397, 1992.
162. Chen, L.T. and Hsu, Y.C., Hemopoesis of the cultured whole mouse embryo, Exp. Hemat., 7, 232, 1979.
163. Mirkes, P.E., Cyclophosphamide teratogenesis: a review, Teratogen. Carcinogen. Mutagen., 5, 75, 1985.
164. Mirkes, P.E. and Cornel, L., A comparison of sodium arsenite- and hyperthermia-induced stress responses and abnormal development in cultured postimplantation rat embryos, Teratology, 46, 251, 1992.
165. Mirkes, P.E., Grace, R.H., and Little, S.A., Developmental regulation of heat shock protein synthesis and HSP 70 RNA accumulation during postimplantation rat embryogenesis, Teratology, 44, 77, 1991.
166. Thayer, J. and Mirkes, P.E., Programmed cell death and N-acetoxy-2-acetylaminofluorene-induced apoptosis in the rat embryo, Teratology, 51, 418, 1995.
167. Sadler, T.W., Liu, E.T., and Augustine, K.A., Antisense targeting of engrailed-1 causes abnormal axis formation in mouse embryos, Teratology, 51, 292, 1995.
168. Sulston, J.E. and Horvitz, H.R., Post-embryonic cell lineages of the nematode, Caenorhabditis elegans, Dev. Biol., 56, 110, 1977.
169. Sulston, J.E., Schierenberg, E., White, J.G., and Thomson, J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans, Dev. Biol., 100, 64, 1983.
170. Kokel, M., Borland, C.Z., DeLong, L., Horvitz, H.R., and Stern, M.J., clr-1 encodes a receptor tyrosine phosphatase that negatively regulates an FGF receptor signaling pathway in Caenorhabditis elegans, Genes Dev., 12, 1425, 1998.
171. Gleason, J.E., Korswagen, H.C., and Eisenmann, D.M., Activation of Wnt signaling bypasses the requirement for RTK/Ras signaling during C. elegans vulval induction, Genes Dev., 16, 1281, 2002.
172. Krishna, S., Maduzia, L.L., and Padgett, R.W., Specificity of TGF-beta signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans, Development, 126, 251, 1999.
173. Morita, K., Flemming, A.J., Sugihara, Y., Mochii, M., Suzuki, Y., Yoshida, S., Wood, W.B., Kohara, Y., Leroi, A.M., and Ueno, N., A Caenorhabditis elegans TGF-beta, DBL-1, controls the expression of LON-1, a PR-related protein, that regulates polyploidization and body length, EMBO J., 21, 1063, 2002.
174. Yoshida, S., Morita, K., Mochii, M., and Ueno, N. Hypodermal expression of Caenorhabditis elegans TGF-beta type I receptor SMA-6 is essential for the growth and maintenance of body length, Dev. Biol., 240, 32, 2001.
175. Berset, T., Hoier, E.F., Battu, G., Canevascini, S., and Hajnal, A., Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development, Science, 291, 2255, 2001.
176. Hermann, G.J., Leung, B., and Priess, J.R., Left-right asymmetry in C. elegans intestine organogenesis involves a LIN-12/Notch signaling pathway, Development, 127, 3429, 2000.
177. Herman M., C. elegans POP-1/TCF functions in a canonical Wnt pathway that controls cell migration and in a noncanonical Wnt pathway that controls cell polarity, Development, 128, 581, 2001.
178. Liu, Q.A. and Hengartner, M.O., The molecular mechanism of programmed cell death in C. elegans. Ann. N. Y. Acad. Sci., 887, 92, 1999.
179. Tzur, Y.B., Hersh, B.M., Horvitz, H.R., and Gruenbaum, Y., Fate of the nuclear lamina during Caenorhabditis elegans apoptosis. J. Struct. Biol. 137, 146, 2002.
180. Schumacher, B., Hofmann, K., Boulton, S., and Gartner, A., The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis, Curr. Biol., 11, 1722, 2001.
181. Fort, D.J., Stover, E.L., Bantle, J.A., and Finch, R.A., Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-Xenopus (FETAX): biotransformation and detoxification, Teratog. Carcinog. Mutagen., 20, 35, 2000.
182. Prati, M., Gornati, R., Boracchi, P., Biganzoli, E., Fortaner, S., Pietra, R., Sabbioni, E. and Bernardini, G., A comparative study of the toxicity of mercury dichloride and methylmercury, assayed by the frog embryo teratogenesis assay - Xenopus (FETAX), Altern. Lab Anim., 30, 23, 2002.
183. Vismara, C., Bacchetta, R., Cacciatore, B., Vailati, G. and Fascio, U., Paraquat embryotoxicity in the Xenopus laevis cleavage phase, Aquat. Toxicol., 55, 85, 2001.
184. Vismara, C., Battista, V.V., Vailati, G., and Bacchetta, R., Paraquat induced embryotoxicity on Xenopus laevis development. Aquat. Toxicol., 49, 171, 2000.
185. Kotyzova, D. and Sundeman, F.W., Maternal exposure to Cd(II) causes malformations of Xenopus laevis embryos, Ann. Clin. Lab. Sci., 28, 224, 1998.
186. Propst, T.L., Fort, D.J., Stover, E.L., Schrock, B., and Bantle, J.A., Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Drug Chem Toxicol., 20, 45, 1997.
187. Fort, D.J., Stover, E.L., Propst, T.L., Faulkner, B.C., Vollmuth, T.A., and Murray, F.J., Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay - Xenopus (FETAX), Food Chem. Toxicol., 36, 591, 1998.
188. Van den Belt, K., Van Puymbroeck, S., and Witters, H., Toxicity of cadmium-contaminated clay to the zebrafish Danio rerio, Arch. Environ. Contam. Toxicol., 38, 191, 2000.
189. Henry, T.R., Spitsbergen, J.M., Hornung, M.W., Abnet, C.C., and Peterson, R.E., Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (Danio rerio), Toxicol. Appl. Pharmacol., 142, 56, 1997.
190. Bresch, H., Beck, H., Ehlermann, D., Schlaszus, H., and Urbanek, M., A long-term toxicity test comprising reproduction and growth of zebrafish with 4-chloroaniline, Arch. Environ. Contam. Toxicol., 19, 419, 1990.
191. Gong, Z., Ju, B., and Wan, H., Green fluorescent protein (GFP) transgenic fish and their applications, Genetica, 111, 213, 2001.
192. Iwama, M., Honda, A., Mori, Y., Alterations of glycosaminoglycans synthesized by chick embryo cartilage treated with 6-amino-nicotinamide, J. Pharmacobiodyn., 6, 613, 1983.
193. Shiga, T., Gaur, V.P., Yamaguchi, K., and Oppenheim, R.W., The development of interneurons in the chick embryo spinal cord following in vivo treatment with retinoic acid, J. Comp. Neurol., 360, 463, 1995.
194. Richman, J.M. and Delgado, J.L., Locally released retinoic acid leads to facial clefts in the chick embryo but does not alter the expression of receptors for fibroblast growth factor, J. Craniofac. Genet. Dev. Biol., 15, 190, 1995.
195. Mattingly, C.J., McLachlan, J.A., and Toscano, W.A., Green fluorescent protein (GFP) as a marker of aryl hydrocarbon receptor (AhR) function in developing zebrafish (Danio rerio), Environ. Health Perspect., 109, 845, 2001.
196. Karkinen-Jaaskelainen, M. and Saxen, L. Advantages of organ culture techniques in teratology, in Tests of Teratogenicity In Vitro, Marois, M., Ed. North Holland Publishers, Amsterdam, 1976, p. 275.
197. Shepard, T.H. and Pious, D., Cell, tissue and organ culture as teratologic tools, in Handbook of Teratology, Wilson, J.G. and Fraser, F.C., Eds. Plenum Press, New York, 1978, p. 71.
198. Trowell. O.A., The culture of mature organs in a synthetic medium, Exp. Cell Res., 16, 118, 1959.
199. Lessmollmann, U., Neubert, D., and Merker, H.-J., Mammalian limb buds differentiating in vitro as a test system for the evaluation of embryotoxic effects, in New Approaches to the Evaluation of Abnormal Embryonic Development, Neubert, D., Merker, H.J., Bedürftig, A., and Kreft, R., Eds., Georg Thieme Verlag, Stuttgart, 1975, p. 99.
200. Friedman, L., Teratological research using in vitro systems. II. Rodent limb bud culture system, Environ. Health Perspect, 72, 211, 1987.
201. Strangeways, T.S.P. and Fell, H.B., Experimental studies on the differentiation of embryonic tissues growing in vivo and in vitro. I. The development of the undifferentiated limb-bud (a) when subcutaneously grafted into the post-embryonic chick and (b) when cultured in vitro, Proc. Roy. Soc. London B, 99, 340, 1926.
202. Aydelotte, M.B. and Kochhar, D.M., Development of mouse limb buds in organ culture: chondrogenesis in the presence of a proline analog, 1-azetidine-2-carboxylic acid, Dev. Biol, 28, 191, 1972.
203. Neubert, D. and Barrach, H.J., Techniques applicable to study morphogenic differentiation of limb buds in organ culture, in Methods in Prenatal Toxicology, Neubert, D., Merker, H.-J., and Kwasigroch, T.E., Eds., George Thieme Publishers, Stuttgart, 241, 1977.
204. Krowke, R.R., Bluth, U., and Neubert, D., In vitro studies on the embryotoxic potential of (bis[tri-n-butyltin])oxide in a limb bud organ culture system, Arch Toxicol, 58, 125, 1986.
205. Kochar, D.M. and Aydelotte, M.B., Susceptible stages and abnormal morphogenesis in the developing mouse limb, analyzed in organ culture after transplacental exposure to vitamin A (retinoic acid), J. Embryol. Exp. Morophol, 31, 721, 1974.
206. Nakamura, H., Analysis of limb anomalies induced in vitro by vitamin A (retinol), Teratology, 12, 61, 1975.
207. Manson, J.M. and Smith, C. C., Influence of cyclophosphamide and 4-ketocyclophosphamide on mouse limb development, Teratology, 15, 291, 1977.
208. Stahlmann, R., Bluth, U., and Neubert, D., Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures, Arch. Toxicol., 57, 163, 1985.
209. Neubert, D., Lessmollmann, U., Hinz, N., Dillman, I., and Fuchs, G., Interference of 6-metcaotopurine riboside, 6-methylmercaptopurine riboside and azathioprine with the morphogenic differentiation of mouse extremities in vivo and in an organ culture, Naunyn-Schmiedebergs Arch. Pharmakol, 289, 1093, 1977.
210. Flint, O.P., The effects of sodium salicylate, cytosine arabinoside, and eserine sulphate on rat limb buds in culture, in Teratology of the Limbs, Merker, H.-J., Hau, H., and Neubert, D., Eds., Walter de Gruyter, Berlin, 1980, p. 325.
211. Tsuchiya, T. and Tanaka, A., Effects of thiabendazole on the mouse limb-bud organ and cell in culture, Toxicol. Lett., 30, 19, 1986.
212. Barrach, H.J., Mark, K.V.D., and Gay, S., Location of type I and type II collagen in developing limb buds of mammalian, in New Approaches to the Elucidation of Abnormal Embryonic Development, Neubert, D. and Merker, H.-J., Eds., Georg Thieme Publishers, Stuttgart, 1975, p. 145.
213. Lilja, S. and Schimmelpfennig, K., Studies on glycosaminoglycans in cultured mouse limb buds, in New Approaches to the Elucidation of Abnormal Embryonic Development, Neubert, D. and Merker, H.-J., Eds., Georg Thieme Publishers, Stuttgart, 1975, p. 241.
214. Kwasigroch, T.E. and Kochhar, D.M., Locomotory behavior of limb bud cells: effects of excess vitamin A in vivo and in vitro, Exp. Cell. Res, 95,269, 1975.
215. Hoffman, C. and Eichele, G., Retinoids in development, in The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed., Sporn, M.B., Roberts, A.B., and Goodman, D. S., Eds., Raven Press, Ltd., New York, 1994, p. 387.
216. Knudsen, T.B., In vitro approaches to the study of embryonic cell death in developmental toxicity, in In Vitro Methods in Developmental Toxicology: Use in Defining Mechanisms and Risk Parameters, Kimmel, G.L. and Kochhar, D.M., Eds., CRC Press, Boca Raton, 1990, p. 129.
217. Pratt, R.M., Dencker, L., and Diewert, V.M., 2,3,7,8-tetrachlorodibenzo-pdioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion, Teratogen. Carcinogen. Mutagen., 4, 427, 1984.
218. Pratt, R.M., Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate, Environ. Health Perspect, 61, 35, 1985.
219. Mino, Y., Mizusawa, H., and Shiota, K., Effects of anticonvulsant drugs on fetal mouse palates cultured in vitro, Reprod. Toxicol, 8, 225, 1994.
220. Abbott, B.D., Harris, M.W., and Birnbaum, L.S., Etiology of retinoic acid-induced cleft palate varies with the embryonic stage, Teratology, 40, 533, 1989.
221. Saxen, I. and Saxen, L., Organ culture in teratology: closure of the palatal shelves as a model system, in New Approaches to the Evaluation of Abnormal Embryonic Development, Neubert, D., Merker, H.J., Bedürftig, A., and Kreft, R., Eds., Georg Thieme Verlag, Stuttgart, 1975, p. 84.
222. Saxen, I., The effect of tetracycline on osteogenesis in vitro, J. Exp. Zool., 162, 269, 1966.
223. Saxen, I., Effects of hydrocortisone on the development in vitro of the secondary palate in two inbred strains of mice, Arch. Oral Biol, 18, 1469, 1973.
224. Abbott, B.D. and Buckalew, A.R., Embryonic palatal responses to teratogens in serum-free organ culture, Teratology, 45, 369, 1992.
225. Shiota, K., Kosazuma, T., Klug, S., and Neubert, D., Development of the fetal mouse palate in suspension organ culture, Acta Anat., 137, 59, 1990.
226. Pratt, R.M., Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate, Environ. Health Perspect, 61, 434, 1985.
227. Pratt, R.M., Receptor-dependent Mechanisms of craniofacial malformations, in Approaches to Elucidate Mechanisms in Teratogenesis, Welsch, F., Ed., Hemisphere, New York, 1987, p. 149.
228. Abbot, B.D. and Pratt, R.M., Retinoids and epidermal growth factor alter embryonic mouse palatal epithelial and mesenchymal cell differentiation in organ culture, J. Craniofac. Gen. Dev. Biol., 7, 219, 1987.
229. Abbott, B.D. and Pratt, R.M., Human embryonic palatal epithelial differentiation is altered by retinoic acid and epidermal growth factor in organ culture, J. Craniofac. Gen. Dev. Biol, 7, 241, 1987.
230. Pratt, R.M., Goulding. E.H., and Abbott, B.D., Retinoic acid inhibits migration of cranial neural crest cells in the cultured mouse embryo, J. Craniofac. Gen. Dev. Biol., 7, 205, 1987.
231. Beck, F., Lloyd, J.B., and Griffiths, A., Lysosomal enzyme inhibition by trypan blue: a theory of teratogenesis, Science, 157, 1180, 1967.
232. Beck, F. and Lowy, A. The effect of cathepsin inhibitor on rat embryos grown in vitro, J. Embryol. Exp. Morphol., 71, 1, 1982.
233. Duncan, R. and Lloyd, J.B., Pinocytosis in the visceral yolk sac. Effects of temperature, metabolic inhibitors and some other modifiers, Biochim. Biophys. Acta, 544, 647, 1978.
234. Stevenson, G.B. and Williams, K.E., Ethanol-induced inhibition of pinocytosis and proteolysis in rat yolk sac in vitro, Development, 99, 247, 1987.
235. Lerman, S., Koszalka, T.R., Jensen, M., Andrew, C.L., Beckman, D.A., and Brent, R.L., In vitro studies on the effect of yolk sac antisera on functions of the visceral yolk sac. I. Pinocytosis and transport of small molecules, Teratology, 34, 335, 1986.
236. Haffen, K., Organ culture and the determination of sex organs, in Tests of Teratogenicity In Vitro, Marois, M., Ed., North Holland Publishers, Amsterdam, 1976, p. 285.
237. DeHaan, R.L., Cell coupling and electrophysiological differentiation of embryonic heart cells, in Tests of Teratogenicity In Vitro, Marois, M., Ed. North Holland Publishers, Amsterdam, 1976, p. 225.
238. Kollar, E. J., The use of organ cultures of embryonic tooth germs for teratological studies, in Tests of Teratogenicity In Vitro, Marois, M., Ed. North Holland Publishers, Amsterdam, 1976, p. 303.
239. Lasnitzki, I., Organ culture, In Animal Cell Culture: A Practical Approach, Freshney, R.I., Ed., IRL Press, Oxford, 1992, p. 213.
240. Fisher, K.R.S. and Fedoroff, S., The development of chick spinal cord in tissue culture, In vitro, 14, 878, 1978.
241. Bird, M.M. and Owen, A., The effect of calcium ionophore A23187 on neurites from embryonic mouse spinal cord explants in culture, J. Electron Microsc. (Tokyo), 49, 379, 2000.
242. Serra, R., Pelton, R.W., and Moses, H.L., TGFb1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures, Development, 120, 2153, 1994.
243. Levesque, B.M., Vosatka, R.J., and Nielsen, H.C., Dihydrotestosterone stimulates branching morphogenesis, cell proliferation, and programmed cell death in mouse embryonic lung explants, Pediatr. Res., 47, 481, 2000.
244. Konigsberg, I.R., Clonal analysis of development, in Tests of Teratogenicity In Vitro, Marois, M., Ed. North Holland Publishers, Amsterdam, 1976, p. 275.
245. Kasten, F.H., Mammalian myocardial cells, in Tissue Culture Methods and Applications, Kruse, Jr., P.F., and Patterson, M.K., Jr., Eds., Academic Press, New York, 1973, p. 72.
246. Zimmerman, B., Effects of matrix influencing substances on chondrocyte in monolayer culture, in Teratology of the Limbs, Merker, H.-J., Hau, H., and Neubert, D., Eds., Walter de Gruyter, Berlin, 1980, p. 207.
247. Coon, H.G., Clonal stability and phenotypic expression of chick cartilage cells in vitro, Proc. Nat. Acad. Sci. U.S.A., 55, 66, 1966.
248. Cahn, R.D. and Cahn, M.B., Heritability of cellular differentiation: clonal growth and expression of differentiation in retinal pigment cells in vitro, Proc. Nat. Acad. Sci. U.S.A., 55, 106, 1966.
249. Eguchi, G. and Okada, T.S., Differentiation of lens tissue from the progeny of chick retinal pigment cells cultured in vitro: a demonstration of a switch of cell types in clonal cell culture, Proc. Nat. Acad. Sci. U.S.A., 70, 1495, 1973.
250. Loring, J., Glimelius, B., Erickson, C., and Weston, J. A., Analysis of developmentally homogeneous neural crest cell populations in vitro, Dev. Biol., 82, 86, 1981.
251. Glimelius, B. and Weston, J. A., Analysis of developmentally homogeneous neural crest cell populations in vitro. II. A tumor-promoter (TPA) delays differentiation and promotes cell proliferation, Dev. Biol., 82, 95, 1981.
252. Kang, K.S., Park, J.E., Ryu, D.Y., and Lee, Y.S., Effects and neuro-toxic mechanisms of 2,2¢,4,4¢,5,5¢-hexachlorobiphenyl and endosulfan in neuronal stem cells, J. Vet. Med. Sci., 63, 1183, 2001
253. Davis, W.L., Crawford, L.A., Cooper, O.J., Farmer, G.R., Thomas, D.L., and Freeman, B.L., Ethanol induces the generation of reactive free radicals by neural crest cells in vitro, J. Craniofac. Genet. Dev. Biol., 10, 277, 1990.
254. Davis, W.L., Crawford, L.A., Cooper, O.J., Farmer, G.R., Thomas, D.L., and Freeman, B.L., Generation of radical oxygen species by neural crest cells treated in vitro with isotretinoin and 4-oxoisotretinoin, J. Craniofac. Genet. Dev. Biol., 10, 295, 1990.
255. Davis, W.L., Jacoby, B.H., Farmer, G.R., and Cooper, O.J., Changes in cytosolic calcium, bleb formation, and cell death in neural crest cells treated with isotretinoin and 4-oxo-isotretinoin, J. Craniofac. Genet. Dev. Biol., 10, 295, 1990.
256. Bonnefoi, M.S., Mitochondrial glutathione and methyl iodide-induced neurotoxicity in primary neural cell cultures, Neuro. Toxicol., 13, 401, 1992.
257. Flint, O.P. and Orton, T.C., An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells, Toxicol. Appl. Pharmacol., 76, 383, 1984.
258. Kistler, A. and Howard, W.B., Testing of retinoids for teratogenicity in vitro: use of micromass limb bud culture, Methods Enzymol., 190, 427, 1990.
259. Kistler, A., Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids, Arch. Toxicol., 60, 403, 1987.
260. Hansen, J.M., Carney, E.W., Harris, C., Altered differentiation in rat and rabbit limb bud micromass cultures by glutathione modulating agents, Free Radic. Biol. Med., 31, 1582, 2001
261. Flint, O.P., Orton, T.C., and Ferguson, R.A., Differentiation of rat embryo cells in culture: response following acute maternal exposure to teratogens and non-teratogens, J. Appl. Toxicol., 4, 109, 1984.
262. Roark, E.F. and Greer, K., Transforming growth factor-beta and bone morphogenetic protein-2 act by distinct mechanisms to promote chick limb cartilage differentiation in vitro, Dev. Dyn., 200, 103, 1994.
263. Lee, Y.S. and Chuong, C.M., Activation of protein kinase A is a pivotal step involved in both BMP-2- and cyclic AMP-induced chondrogenesis, J. Cell Physiol., 170, 153, 1997.
264. Boskey, A.L., Paschalis, E.P., Binderman, I., and Doty, S.B., BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures, J. Cell Biochem., 84, 509, 2002.
265. Kruger, M., Mennerich, D., Fees, S., Schafer, R., Mundlos, S. and Braun T., Sonic hedgehog is a survival factor for hypaxial muscles during mouse development, Development, 128, 743, 2001.
266. Whittaker, S.G., Wroble, J.T., Silbernagel, S.M. and Faustman, E.M. Characterization of cytoskeletal and neuronal markers in micromass cultures of rat embryonic midbrain cells, Cell. Biol. Toxicol., 9, 359,1993.